Global Recombinant DNA Technology Market Research Report 2023
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant DNA Technology Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Therapeutic Agent
1.2.3 Vaccine
1.2.4 Biotech Crops
1.2.5 Specialty Chemicals
1.3 Market by Application
1.3.1 Global Recombinant DNA Technology Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Biotechnology and Pharmaceutical Companies
1.3.3 Academic & Government Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant DNA Technology Market Perspective (2018-2029)
2.2 Recombinant DNA Technology Growth Trends by Region
2.2.1 Global Recombinant DNA Technology Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Recombinant DNA Technology Historic Market Size by Region (2018-2023)
2.2.3 Recombinant DNA Technology Forecasted Market Size by Region (2024-2029)
2.3 Recombinant DNA Technology Market Dynamics
2.3.1 Recombinant DNA Technology Industry Trends
2.3.2 Recombinant DNA Technology Market Drivers
2.3.3 Recombinant DNA Technology Market Challenges
2.3.4 Recombinant DNA Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant DNA Technology Players by Revenue
3.1.1 Global Top Recombinant DNA Technology Players by Revenue (2018-2023)
3.1.2 Global Recombinant DNA Technology Revenue Market Share by Players (2018-2023)
3.2 Global Recombinant DNA Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Recombinant DNA Technology Revenue
3.4 Global Recombinant DNA Technology Market Concentration Ratio
3.4.1 Global Recombinant DNA Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant DNA Technology Revenue in 2022
3.5 Recombinant DNA Technology Key Players Head office and Area Served
3.6 Key Players Recombinant DNA Technology Product Solution and Service
3.7 Date of Enter into Recombinant DNA Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant DNA Technology Breakdown Data by Type
4.1 Global Recombinant DNA Technology Historic Market Size by Type (2018-2023)
4.2 Global Recombinant DNA Technology Forecasted Market Size by Type (2024-2029)
5 Recombinant DNA Technology Breakdown Data by Application
5.1 Global Recombinant DNA Technology Historic Market Size by Application (2018-2023)
5.2 Global Recombinant DNA Technology Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Recombinant DNA Technology Market Size (2018-2029)
6.2 North America Recombinant DNA Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Recombinant DNA Technology Market Size by Country (2018-2023)
6.4 North America Recombinant DNA Technology Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant DNA Technology Market Size (2018-2029)
7.2 Europe Recombinant DNA Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Recombinant DNA Technology Market Size by Country (2018-2023)
7.4 Europe Recombinant DNA Technology Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant DNA Technology Market Size (2018-2029)
8.2 Asia-Pacific Recombinant DNA Technology Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Recombinant DNA Technology Market Size by Region (2018-2023)
8.4 Asia-Pacific Recombinant DNA Technology Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant DNA Technology Market Size (2018-2029)
9.2 Latin America Recombinant DNA Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Recombinant DNA Technology Market Size by Country (2018-2023)
9.4 Latin America Recombinant DNA Technology Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant DNA Technology Market Size (2018-2029)
10.2 Middle East & Africa Recombinant DNA Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Recombinant DNA Technology Market Size by Country (2018-2023)
10.4 Middle East & Africa Recombinant DNA Technology Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Monsanto Company
11.1.1 Monsanto Company Company Detail
11.1.2 Monsanto Company Business Overview
11.1.3 Monsanto Company Recombinant DNA Technology Introduction
11.1.4 Monsanto Company Revenue in Recombinant DNA Technology Business (2018-2023)
11.1.5 Monsanto Company Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Recombinant DNA Technology Introduction
11.2.4 Roche Revenue in Recombinant DNA Technology Business (2018-2023)
11.2.5 Roche Recent Development
11.3 Biogen
11.3.1 Biogen Company Detail
11.3.2 Biogen Business Overview
11.3.3 Biogen Recombinant DNA Technology Introduction
11.3.4 Biogen Revenue in Recombinant DNA Technology Business (2018-2023)
11.3.5 Biogen Recent Development
11.4 Amgen
11.4.1 Amgen Company Detail
11.4.2 Amgen Business Overview
11.4.3 Amgen Recombinant DNA Technology Introduction
11.4.4 Amgen Revenue in Recombinant DNA Technology Business (2018-2023)
11.4.5 Amgen Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Recombinant DNA Technology Introduction
11.5.4 Novartis Revenue in Recombinant DNA Technology Business (2018-2023)
11.5.5 Novartis Recent Development
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Detail
11.6.2 Eli Lilly and Company Business Overview
11.6.3 Eli Lilly and Company Recombinant DNA Technology Introduction
11.6.4 Eli Lilly and Company Revenue in Recombinant DNA Technology Business (2018-2023)
11.6.5 Eli Lilly and Company Recent Development
11.7 GenScript
11.7.1 GenScript Company Detail
11.7.2 GenScript Business Overview
11.7.3 GenScript Recombinant DNA Technology Introduction
11.7.4 GenScript Revenue in Recombinant DNA Technology Business (2018-2023)
11.7.5 GenScript Recent Development
11.8 Pfizer Inc.
11.8.1 Pfizer Inc. Company Detail
11.8.2 Pfizer Inc. Business Overview
11.8.3 Pfizer Inc. Recombinant DNA Technology Introduction
11.8.4 Pfizer Inc. Revenue in Recombinant DNA Technology Business (2018-2023)
11.8.5 Pfizer Inc. Recent Development
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Detail
11.9.2 Novo Nordisk Business Overview
11.9.3 Novo Nordisk Recombinant DNA Technology Introduction
11.9.4 Novo Nordisk Revenue in Recombinant DNA Technology Business (2018-2023)
11.9.5 Novo Nordisk Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Detail
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Recombinant DNA Technology Introduction
11.10.4 Sanofi Revenue in Recombinant DNA Technology Business (2018-2023)
11.10.5 Sanofi Recent Development
11.11 Merck KGaA
11.11.1 Merck KGaA Company Detail
11.11.2 Merck KGaA Business Overview
11.11.3 Merck KGaA Recombinant DNA Technology Introduction
11.11.4 Merck KGaA Revenue in Recombinant DNA Technology Business (2018-2023)
11.11.5 Merck KGaA Recent Development
11.12 Profacgen
11.12.1 Profacgen Company Detail
11.12.2 Profacgen Business Overview
11.12.3 Profacgen Recombinant DNA Technology Introduction
11.12.4 Profacgen Revenue in Recombinant DNA Technology Business (2018-2023)
11.12.5 Profacgen Recent Development
11.13 Biocon
11.13.1 Biocon Company Detail
11.13.2 Biocon Business Overview
11.13.3 Biocon Recombinant DNA Technology Introduction
11.13.4 Biocon Revenue in Recombinant DNA Technology Business (2018-2023)
11.13.5 Biocon Recent Development
11.14 GlaxoSmithKline
11.14.1 GlaxoSmithKline Company Detail
11.14.2 GlaxoSmithKline Business Overview
11.14.3 GlaxoSmithKline Recombinant DNA Technology Introduction
11.14.4 GlaxoSmithKline Revenue in Recombinant DNA Technology Business (2018-2023)
11.14.5 GlaxoSmithKline Recent Development
11.15 Cibus
11.15.1 Cibus Company Detail
11.15.2 Cibus Business Overview
11.15.3 Cibus Recombinant DNA Technology Introduction
11.15.4 Cibus Revenue in Recombinant DNA Technology Business (2018-2023)
11.15.5 Cibus Recent Development
11.16 Horizon Discovery Group
11.16.1 Horizon Discovery Group Company Detail
11.16.2 Horizon Discovery Group Business Overview
11.16.3 Horizon Discovery Group Recombinant DNA Technology Introduction
11.16.4 Horizon Discovery Group Revenue in Recombinant DNA Technology Business (2018-2023)
11.16.5 Horizon Discovery Group Recent Development
11.17 New England Biolabs
11.17.1 New England Biolabs Company Detail
11.17.2 New England Biolabs Business Overview
11.17.3 New England Biolabs Recombinant DNA Technology Introduction
11.17.4 New England Biolabs Revenue in Recombinant DNA Technology Business (2018-2023)
11.17.5 New England Biolabs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Recombinant DNA Technology Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Therapeutic Agent
Table 3. Key Players of Vaccine
Table 4. Key Players of Biotech Crops
Table 5. Key Players of Specialty Chemicals
Table 6. Global Recombinant DNA Technology Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Recombinant DNA Technology Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Recombinant DNA Technology Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Recombinant DNA Technology Market Share by Region (2018-2023)
Table 10. Global Recombinant DNA Technology Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Recombinant DNA Technology Market Share by Region (2024-2029)
Table 12. Recombinant DNA Technology Market Trends
Table 13. Recombinant DNA Technology Market Drivers
Table 14. Recombinant DNA Technology Market Challenges
Table 15. Recombinant DNA Technology Market Restraints
Table 16. Global Recombinant DNA Technology Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Recombinant DNA Technology Market Share by Players (2018-2023)
Table 18. Global Top Recombinant DNA Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA Technology as of 2022)
Table 19. Ranking of Global Top Recombinant DNA Technology Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Recombinant DNA Technology Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Recombinant DNA Technology Product Solution and Service
Table 23. Date of Enter into Recombinant DNA Technology Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Recombinant DNA Technology Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Recombinant DNA Technology Revenue Market Share by Type (2018-2023)
Table 27. Global Recombinant DNA Technology Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Recombinant DNA Technology Revenue Market Share by Type (2024-2029)
Table 29. Global Recombinant DNA Technology Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Recombinant DNA Technology Revenue Market Share by Application (2018-2023)
Table 31. Global Recombinant DNA Technology Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Recombinant DNA Technology Revenue Market Share by Application (2024-2029)
Table 33. North America Recombinant DNA Technology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Recombinant DNA Technology Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Recombinant DNA Technology Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Recombinant DNA Technology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Recombinant DNA Technology Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Recombinant DNA Technology Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Recombinant DNA Technology Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Recombinant DNA Technology Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Recombinant DNA Technology Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Recombinant DNA Technology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Recombinant DNA Technology Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Recombinant DNA Technology Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Recombinant DNA Technology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Recombinant DNA Technology Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Recombinant DNA Technology Market Size by Country (2024-2029) & (US$ Million)
Table 48. Monsanto Company Company Detail
Table 49. Monsanto Company Business Overview
Table 50. Monsanto Company Recombinant DNA Technology Product
Table 51. Monsanto Company Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 52. Monsanto Company Recent Development
Table 53. Roche Company Detail
Table 54. Roche Business Overview
Table 55. Roche Recombinant DNA Technology Product
Table 56. Roche Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 57. Roche Recent Development
Table 58. Biogen Company Detail
Table 59. Biogen Business Overview
Table 60. Biogen Recombinant DNA Technology Product
Table 61. Biogen Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 62. Biogen Recent Development
Table 63. Amgen Company Detail
Table 64. Amgen Business Overview
Table 65. Amgen Recombinant DNA Technology Product
Table 66. Amgen Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 67. Amgen Recent Development
Table 68. Novartis Company Detail
Table 69. Novartis Business Overview
Table 70. Novartis Recombinant DNA Technology Product
Table 71. Novartis Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 72. Novartis Recent Development
Table 73. Eli Lilly and Company Company Detail
Table 74. Eli Lilly and Company Business Overview
Table 75. Eli Lilly and Company Recombinant DNA Technology Product
Table 76. Eli Lilly and Company Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 77. Eli Lilly and Company Recent Development
Table 78. GenScript Company Detail
Table 79. GenScript Business Overview
Table 80. GenScript Recombinant DNA Technology Product
Table 81. GenScript Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 82. GenScript Recent Development
Table 83. Pfizer Inc. Company Detail
Table 84. Pfizer Inc. Business Overview
Table 85. Pfizer Inc. Recombinant DNA Technology Product
Table 86. Pfizer Inc. Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 87. Pfizer Inc. Recent Development
Table 88. Novo Nordisk Company Detail
Table 89. Novo Nordisk Business Overview
Table 90. Novo Nordisk Recombinant DNA Technology Product
Table 91. Novo Nordisk Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 92. Novo Nordisk Recent Development
Table 93. Sanofi Company Detail
Table 94. Sanofi Business Overview
Table 95. Sanofi Recombinant DNA Technology Product
Table 96. Sanofi Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 97. Sanofi Recent Development
Table 98. Merck KGaA Company Detail
Table 99. Merck KGaA Business Overview
Table 100. Merck KGaA Recombinant DNA Technology Product
Table 101. Merck KGaA Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 102. Merck KGaA Recent Development
Table 103. Profacgen Company Detail
Table 104. Profacgen Business Overview
Table 105. Profacgen Recombinant DNA Technology Product
Table 106. Profacgen Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 107. Profacgen Recent Development
Table 108. Biocon Company Detail
Table 109. Biocon Business Overview
Table 110. Biocon Recombinant DNA Technology Product
Table 111. Biocon Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 112. Biocon Recent Development
Table 113. GlaxoSmithKline Company Detail
Table 114. GlaxoSmithKline Business Overview
Table 115. GlaxoSmithKline Recombinant DNA Technology Product
Table 116. GlaxoSmithKline Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 117. GlaxoSmithKline Recent Development
Table 118. Cibus Company Detail
Table 119. Cibus Business Overview
Table 120. Cibus Recombinant DNA Technology Product
Table 121. Cibus Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 122. Cibus Recent Development
Table 123. Horizon Discovery Group Company Detail
Table 124. Horizon Discovery Group Business Overview
Table 125. Horizon Discovery Group Recombinant DNA Technology Product
Table 126. Horizon Discovery Group Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 127. Horizon Discovery Group Recent Development
Table 128. New England Biolabs Company Detail
Table 129. New England Biolabs Business Overview
Table 130. New England Biolabs Recombinant DNA Technology Product
Table 131. New England Biolabs Revenue in Recombinant DNA Technology Business (2018-2023) & (US$ Million)
Table 132. New England Biolabs Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Recombinant DNA Technology Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Recombinant DNA Technology Market Share by Type: 2022 VS 2029
Figure 3. Therapeutic Agent Features
Figure 4. Vaccine Features
Figure 5. Biotech Crops Features
Figure 6. Specialty Chemicals Features
Figure 7. Global Recombinant DNA Technology Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Recombinant DNA Technology Market Share by Application: 2022 VS 2029
Figure 9. Biotechnology and Pharmaceutical Companies Case Studies
Figure 10. Academic & Government Research Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. Recombinant DNA Technology Report Years Considered
Figure 13. Global Recombinant DNA Technology Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Recombinant DNA Technology Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Recombinant DNA Technology Market Share by Region: 2022 VS 2029
Figure 16. Global Recombinant DNA Technology Market Share by Players in 2022
Figure 17. Global Top Recombinant DNA Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA Technology as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Recombinant DNA Technology Revenue in 2022
Figure 19. North America Recombinant DNA Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Recombinant DNA Technology Market Share by Country (2018-2029)
Figure 21. United States Recombinant DNA Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Recombinant DNA Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Recombinant DNA Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Recombinant DNA Technology Market Share by Country (2018-2029)
Figure 25. Germany Recombinant DNA Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Recombinant DNA Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Recombinant DNA Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Recombinant DNA Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Recombinant DNA Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Recombinant DNA Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Recombinant DNA Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Recombinant DNA Technology Market Share by Region (2018-2029)
Figure 33. China Recombinant DNA Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Recombinant DNA Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Recombinant DNA Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Recombinant DNA Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Recombinant DNA Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Recombinant DNA Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Recombinant DNA Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Recombinant DNA Technology Market Share by Country (2018-2029)
Figure 41. Mexico Recombinant DNA Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Recombinant DNA Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Recombinant DNA Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Recombinant DNA Technology Market Share by Country (2018-2029)
Figure 45. Turkey Recombinant DNA Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Recombinant DNA Technology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Monsanto Company Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 48. Roche Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 49. Biogen Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 50. Amgen Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 51. Novartis Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 52. Eli Lilly and Company Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 53. GenScript Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 54. Pfizer Inc. Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 55. Novo Nordisk Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 56. Sanofi Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 57. Merck KGaA Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 58. Profacgen Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 59. Biocon Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 61. Cibus Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 62. Horizon Discovery Group Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 63. New England Biolabs Revenue Growth Rate in Recombinant DNA Technology Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed